New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 18, 2013
17:33 EDTESRXExpress Scripts sees FY13 EPS $4.20-$4.30, consensus $4.20
Total adjusted claims are expected to grow 5% to 7% from 1,395.7 million adjusted claims reported in 2012 . Selling, general and administrative expense is expected to decline 8% to 10% from $2,365.9 million reported on an adjusted basis in 2012 and EBITDA per adjusted claim is expected to grow 15% to 18% from $3.87 reported on an adjusted basis in 2012.
News For ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 28, 2015
15:06 EDTESRXNotable companies reporting after market close
Subscribe for More Information
April 23, 2015
13:16 EDTESRXPharmacies, PBMs seen as potential buyers after Omnicare said to explore sale
Subscribe for More Information
12:08 EDTESRXLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
April 15, 2015
11:51 EDTESRXExpress Scripts down 2% as Walgreens speaks at analyst day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use